| Intervention (n= 383) | Standard control (n= 102) | Three-month control (n= 100) a | Between-groups differences | |
---|---|---|---|---|---|
Post-test | Â | Â | Â | Â | |
Knowledge | Insufficient (≤50% correct) | 146 (38.1%) | 95 (93.1%) |  | Χ2(1 9 7.53, P <.001 |
 | Sufficient | 237 (61.9%) | 7 (6.9%) |  | |
Attitudes | Negative | 284 (74.9%) | 61 (61.6%) |  | Χ2(2) = 12.64, P = .002 |
 | Neutral | 72 (19.0%) | 35 (35.4%) |  | |
 | Positive | 23 (6.1%) | 3 (3.0%) |  | |
Intention for uptake | Not likely | 323 (85.2%) | 78 (77.2%) |  | Χ2(2) = 6.38, P = .041 |
 | Neutral | 40 (10.6%) | 20 (19.8%) |  | |
 | Likely | 16 (4.2%) | 3 (3.0%) |  | |
Three-month follow-up | Â | Â | Â | Â | |
Knowledge | Insufficient (≤ 50% correct) | 288 (75.2%) | 87 (85.3%) | 88 (88.0%) | Χ2(2) = 10.71, P = .005 |
 | Sufficient | 95 (24.8%) | 15 (14.7%) | 12 (12.0%) | |
Attitudes | Negative | 280 (75.1%) | 68 (69.4%) | 59 (62.8%) | X2(4) = 7.84, P = .098 |
 | Neutral | 83 (22.3%) | 24 (24.5%) | 30 (31.9%) | |
 | Positive | 10 (2.7%) | 6 (6.1%) | 5 (5.3%) | |
Uptake at follow-up | No decision | 171 (44.8%) | 67 (65.7%) | 70 (70.0%) | Χ2(4) = 29.06, P <.001 |
 | Take tamoxifen | 0 | 0 | 0 | |
 | Take raloxifenea | 2 (0.5%) | 0 | 0 | |
 | Decided no drug | 209 (54.7%) | 35 (34.3%) | 30 (30.0%) |